Baseline and follow-up means (SD) and adjusted treatment effects for the components of the vascular risk score
| Standard care, N=156 | CPAP therapy, N=154 | |||||
|---|---|---|---|---|---|---|
| Outcome measure | Baseline | Follow-up | Baseline | Follow-up | Adjusted treatment effect (95%CI) | p Value |
| Systolic BP (mmHg) | 130.1 (13.0) | 129.8 (12.0) | 129.7 (11.6) | 131.1 (13.4) | +1.8 (0.0 to +3.5) | 0.049 |
| Cholesterol (mmol/litre) | 5.2 (1.1) | 5.1 (1.2) | 5.3 (1.2) | 5.1 (1.1) | 0.0 (−0.2 to +0.1) | 0.68 |
| Creatinine (µmol/litre) | 96.3 (19.2) | 94.8 (19.9) | 93.9 (14.3) | 92.8 (15.5) | +0.2 (−1.8 to +2.2) | 0.82 |
| Current smoker (%) | 22 (14.1) | 19 (12.2) | 10 (6.5) | 12 (7.8) | ||
| Diabetic (%) | 30 (19.2) | 33 (21.2) | 19 (12.3) | 20 (13.0) | ||
| Left ventricular hypertrophy (%) | 2 (1.3) | 1 (0.6) | 2 (1.3) | 4 (2.6) | ||
| Myocardial infarction (%) | 9 (5.8) | 9 (5.8) | 9 (5.8) | 9 (5.8) | ||
| Stroke (%) | 1 (0.6) | 1 (0.6) | 2 (1.3) | 2 (1.3) | ||
BP, blood pressure; CPAP, continuous positive airway pressure.